*ST聚龍(300202.SZ):公司及實控人柳長慶、柳永詮被證監會立案調查
格隆匯7月13日丨*ST聚龍(300202.SZ)公佈,公司及實際控制人柳長慶、柳永詮於近日收到中國證券監督管理委員會下發的《調查通知書》(遼證調查字202172號、202173號、202174號),因聚龍股份、柳長慶、柳永詮涉嫌信息披露違法違規,根據《中華人民共和國證券法》的有關規定,決定對聚龍股份、柳長慶、柳永詮進行立案調查。
此次調查不會對公司日常生產經營活動產生重大影響,亦不影響柳長慶、柳永詮的正常履職,公司及子公司目前生產經營秩序正常,各項業務穩步推進。在調查期間,聚龍股份、柳長慶、柳永詮將積極配合中國證券監督管理委員會的調查工作,並嚴格按照監管要求履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.